dr olofsson - HEALTHY
Nasdaq: PreveCeutical's Subsidary, Biogene Therapeutics Announces Strategic Appointments: Dr. Linnea Olofsson as Chief Scientific Officer and Dr. Harry Parekh as Chief Research Officer
May 31, 2026
Nasdaq: PreveCeutical's Subsidary, Biogene Therapeutics Announces Strategic Appointments: Dr. Linnea Olofsson as Chief Scientific Officer and Dr. Harry Parekh as Chief Research Officer PreveCeutical's Subsidary, Biogene Therapeutics Announces Strategic Appointments: Dr.
Context Explanation
Linnea Olofsson as Chief Scientific Officer and Dr. Harry Parekh as Chief Research Officer